Johnson & Johnson Innovation - JJDC, Inc.'s Net Worth

$506 Million

Estimate Recalculated Feb 28, 2024 08:04PM EST

Who is Johnson & Johnson Innovation - JJDC, Inc.?

Johnson & Johnson Innovation - JJDC, Inc. has an estimated net worth of $506 Million. This is based on reported shares across multiple companies, which include CVRx, Inc., Fusion Pharmaceuticals Inc., Provention Bio, Inc., Inspire Medical Systems, Inc., ACHILLION PHARMACEUTICALS INC, Minerva Neurosciences, Inc., Protagonist Therapeutics, Inc, AQUINOX PHARMACEUTICALS, INC, NEVRO CORP, Aldeyra Therapeutics, Inc., GENOCEA BIOSCIENCES, INC., TENGION INC, BARRIER THERAPEUTICS INC, IMMUNICON CORP, CRITICAL THERAPEUTICS INC, UNIVERSAL BIOSENSORS INC, and MeiraGTx Holdings plc.

SEC CIK

Johnson & Johnson Innovation - JJDC, Inc.'s CIK is 0000924020

Past Insider Trading and Trends

2014 was Johnson & Johnson Innovation - JJDC, Inc.'s most active year for acquiring shares with 9 total transactions. Johnson & Johnson Innovation - JJDC, Inc.'s most active month to acquire stocks was the month of May. 2014 was Johnson & Johnson Innovation - JJDC, Inc.'s most active year for disposing of shares, totalling 38 transactions. Johnson & Johnson Innovation - JJDC, Inc.'s most active month to dispose stocks was the month of August. 2020 saw Johnson & Johnson Innovation - JJDC, Inc. paying a total of $12,325,000.00 for 3,759,634 shares, this is the most they've acquired in one year. In 2017 Johnson & Johnson Innovation - JJDC, Inc. cashed out on 22,259,602 shares for a total of $50,510,590.73, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
0
0
Sep 15
Form 3/A
0
0
Form 3
0
0
Form 4
-100.00%
-3.50M
0
Sep 15
Form 4
3.5M
3.5M
Jul 2
Form 3
0
0
No matching records found

Fusion Pharmaceuticals Inc. (FUSN) Snapshot price: $11.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.67M
$17.00
3.67M
Jun 30
Form 3
0
0
No matching records found

Provention Bio, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.4M
2.4M
Jul 19
Form 3
0
0
No matching records found

Inspire Medical Systems, Inc. (INSP) Snapshot price: $205.45

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
235.25K
235.25K
May 7
Form 3
0
0
No matching records found

ACHILLION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-18.37M
$2.75
-$50,510,201.50
0
Nov 20
Form 3
0
0
No matching records found